News Digging > News > EU lays out pros and cons to onshoring more API production
EU lays out pros and cons to onshoring more API production
EU lays out pros and cons to onshoring more API production,As the US embarks on a billion-dollar initiative to onshore active pharmaceutical ingredient (API) manufacturing, the European Union released a report earlier this month weighing the pros and cons of any possible reshoring of API production. The 58-page report notes that over the past decade, medicine shortages have been increasing

EU lays out pros and cons to onshoring more API production

As the US embarks on a billion-dollar initiative to onshore active pharmaceutical ingredient (API) manufacturing, the European Union released a report earlier this month weighing the pros and cons of any possible reshoring of API production. The 58-page report notes that over the past decade, medicine shortages have been increasing